• News
  • Will COVID-19 harm or help pharma's access to...
News - published on 10 Jul 2020

Will COVID-19 harm or help pharma's access to medicine efforts, asks 2021 Access to Medicine Index

The next Access to Medicine Index will be published in January 2021 – one year after China imposed the first lockdown to control COVID-19. 

The 2021 Index will capture how the world's largest pharmaceutical companies are responding to COVID-19, particularly when it comes to pandemic preparedness. It will also assess their access-to-medicine programmes more broadly, including for HIV/AIDS, malaria, TB, diabetes and cancer.

Explore further

Get in touch

Back to top |